Shares of Mead Johnson Nutrition CO (NYSE:MJN) have earned a consensus rating of “Hold” from the fifteen analysts that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating and thirteen have issued a hold rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $82.50.
A number of research firms have issued reports on MJN. BidaskClub raised Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a research report on Wednesday, June 14th. Canaccord Genuity reissued a “speculative buy” rating on shares of Mead Johnson Nutrition CO in a research report on Wednesday, July 5th. BMO Capital Markets reissued a “hold” rating and set a $90.00 price target on shares of Mead Johnson Nutrition CO in a research report on Thursday, June 15th. Finally, Zacks Investment Research downgraded Mead Johnson Nutrition CO from a “hold” rating to a “sell” rating in a research report on Friday, April 28th.
Mead Johnson Nutrition CO (NYSE MJN) traded down 0.01% during trading on Friday, hitting $89.98. The stock had a trading volume of 11,923,467 shares. The stock’s 50-day moving average is $89.62 and its 200 day moving average is $84.34. Mead Johnson Nutrition CO has a one year low of $69.25 and a one year high of $94.40.
COPYRIGHT VIOLATION NOTICE: “Mead Johnson Nutrition CO (NYSE:MJN) Receives Average Recommendation of “Hold” from Analysts” was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/08/10/brokerages-set-mead-johnson-nutrition-co-nysemjn-price-target-at-83-64-updated.html.
Several institutional investors have recently bought and sold shares of MJN. Vanguard Group Inc. raised its position in Mead Johnson Nutrition CO by 2.2% in the first quarter. Vanguard Group Inc. now owns 12,206,341 shares of the company’s stock valued at $1,087,341,000 after buying an additional 266,416 shares during the period. BlackRock Inc. raised its position in Mead Johnson Nutrition CO by 2,802.8% in the first quarter. BlackRock Inc. now owns 11,394,361 shares of the company’s stock valued at $1,015,011,000 after buying an additional 11,001,837 shares during the period. State Street Corp raised its position in Mead Johnson Nutrition CO by 0.5% in the first quarter. State Street Corp now owns 7,709,238 shares of the company’s stock valued at $686,744,000 after buying an additional 36,271 shares during the period. York Capital Management Global Advisors LLC bought a new position in Mead Johnson Nutrition CO during the first quarter valued at approximately $309,688,000. Finally, Morgan Stanley raised its position in Mead Johnson Nutrition CO by 181.8% in the first quarter. Morgan Stanley now owns 1,939,244 shares of the company’s stock valued at $172,748,000 after buying an additional 1,251,041 shares during the period. 88.40% of the stock is owned by institutional investors.
About Mead Johnson Nutrition CO
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.
